Not all patients with CLL require therapy. Despite all the latest innovations, the iwCLL however suggests watchful observation for sufferers with asymptomatic condition.86 This recommendation is based on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Se